Weight loss drugs may lower risk of dementia, stroke: Study
Patients taking semaglutide or tirzepatide medications — active ingredients in weight loss drugs such as Ozempic, Mounjaro and Wegovy — showed a lower risk of developing certain diseases compared to those taking other, similar medications.
Those include neurodegenerative diseases, such as dementia and Alzheimer's, and cerebrovascular disease, which manifests in strokes, brain aneurysms and more.
Researchers analyzed the health developments over seven years in 60,000 adults aged 40 or older diagnosed with both Type 2 diabetes and obesity, as recorded by the TriNetX U.S. network.
The patients were all users of semaglutide, tirzepatide or other GLP-1 anti-diabetes drugs from December 2017 through June 2024.
The effects were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Researchers acknowledged more clinical trials are needed to corroborate their initial findings, but they maintained the data 'represents one of the most recent clinical database–driven analyses to investigate the neuroprotective and cerebrovascular associations of newer GLP-1RAs' for some patients.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
‘Star Trek: Starfleet Academy' Debuts Hopeful First Trailer With Holly Hunter and Paul Giamatti
'Star Trek: Starfleet Academy,' the newest series in the nearly 60-year-old franchise, warped into San Diego Comic-Con on Saturday with an introduction of its full cast and the first trailer for the show, which will debut in early 2026. The series takes place in the 32nd century after the events of 'Star Trek: Discovery,' with Starfleet relaunching the titular educational institution outside of San Francisco after the Federation's absence on Earth for more than 120 years. More from Variety 'American Dad' Producers on No Longer Getting to Swear as They Return to Fox; Upcoming Guest Stars Include RuPaul, Chris Pine 'The Simpsons' Upcoming Guests Include Kieran Culkin, Viola Davis, Idris Elba; Matt Groening on How to Liberate Parents from MAGA: 'Delete Fox News' 'Star Trek: Strange New Worlds' Teases Puppet Episode for Season 4 'We look at the generation now that is inheriting all of this division and all these major issues,' executive producer Alex Kurtzman said on the Hall H stage. 'We wanted to create a show that anchored us back to [Gene] Rodneyberry's essential vision of hope. How do you find it, how do you rebuild it?' Oscar-winner Holly Hunter plays Nahla Ake, the school's chancellor and the captain of the USS Athena; she greets the new class of cadets in the teaser, as it cuts to the cast exploring various parts of the campus. The teaser ends with a shot of Paul Giamatti as the season's main villain, Nus Braka, who is part-Klingon, part-Tellarite and is described in a Paramount release as 'a man with an ominous past connected to one of our cadets.' The main cadets on the show were revealed as: • Caleb Mir (Sandro Rosta), 'an orphan with a troubled past, and unlikely Starfleet cadet.'• Jay-Den Kraag (Karim Diané), 'a Klingon cadet who dreams of becoming a medical officer.'• Series Acclimation Mil (Kerrice Brooks), a.k.a. Sam, 'the first of her kind to ever attend Starfleet Academy.'• Darem Reymi (George Hawkins), 'an aspiring captain from a wealthy home world.'• Genesis Lythe (Bella Shepard),' an admiral's daughter determined to make her own name in Starfleet.' Other new characters include Tarima Sadal (Zoë Steiner), 'a Betazoid and daughter of the president of Betazed' and Commander Lura Thok (recurring guest star Gina Yashere), 'a Klingon/Jem'Hadar hybrid who is the chancellor's First Officer and Cadet Master.' Picardo is recurring his 'Star Trek: Voyager' character the Doctor, and Tig Notaro and Oded Fehr are reprising their 'Discovery' roles of Jett Reno and Admiral Vance, respectively. Best of Variety New Movies Out Now in Theaters: What to See This Week 'Harry Potter' TV Show Cast Guide: Who's Who in Hogwarts? Final Emmy Predictions: Talk Series and Scripted Variety - New Blood Looks to Tackle Late Night Staples
Yahoo
26 minutes ago
- Yahoo
Wells Fargo Raises PT on Health Catalyst, Inc. (HCAT); Maintains ‘Buy' Rating
Health Catalyst, Inc. (NASDAQ:HCAT), having a share price under $10, strong hedge fund interest, and a low price-to-earnings ratio, ranks among the . A data center operator working on a rack of servers, emphasizing the company's cloud services. On July 1, 2025, Wells Fargo set its price target at $10 for Health Catalyst, Inc. (NASDAQ:HCAT), maintaining a 'Buy' rating. HCAT's shares are currently trading at around $4, implying a significant upside as per the analyst. The analyst believes that Health Catalyst, Inc. (NASDAQ:HCAT) is valued much lower than its peers, which sets the company up for future growth through consistent performance. The firm expects positive growth in the company's bookings in the upcoming Q2, which is likely to boost investor sentiment. Meanwhile, the company's strong revenue visibility for 2025 is noted, along with an anticipated acceleration in its DOS client growth. Looking ahead, the analyst expects the company to improve its dollar-based retention rate, enhancing its customer loyalty and revenue base. Legislative uncertainties, on the other hand, are expected to be short-term concerns with minimal long-term impact. Lastly, the company's EBITDA growth was also highlighted as a key reason for the optimistic outlook. With Health Catalyst Ignite, a cloud-based data and analytics platform, Health Catalyst, Inc. (NASDAQ:HCAT) serves healthcare entities, enhancing clinical, financial, and operational results. It is included in our list of the best cloud stocks. While we acknowledge the potential of HCAT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 14 Cheap Transportation Stocks to Buy According to Analysts and 11 Best Mineral Stocks to Buy According to Hedge Funds. Disclosure: None.
Yahoo
26 minutes ago
- Yahoo
Marine veteran's brain returned by funeral home in an unmarked and leaking box, lawsuit claims
A couple is suing two funeral homes after their veteran son's brain was returned in an unmarked cardboard box that was leaking 'biohazardous liquid,' a lawsuit alleges. Lawrence and Abbey Butler are suing Nix & Nix Funeral Homes in Pennsylvania and Southern Cremations & Funeral in Georgia for the 'mishandling' of the remains of their son Timothy Garlington, a Marine veteran who died in November 2023. He died in Georgia, but was originally from Pennsylvania. In November, the couple hired Southern Cremations & Funerals to transport their son's remains to Nix & Nix Funeral Home in Philadelphia. A week later, Lawrence Butler picked up a 'white, unmarked cardboard box' that the couple thought contained their son's personal belongings, the filing states. The box began to smell and leak fluids in Butler's car. When the couple tried to remove the box, 'biohazardous liquid spilled' onto them, the lawsuit alleges. They reached out to the funeral homes to learn that the box contained their late son's brain. "The family has been destroyed twice," their lawyer, L. Chris Stewart, told Fox 5. The couple says they suffered 'serious mental and emotional distress' as a result of the funeral homes' mishandling of their son's remains, the suit stated. It called the defendants' conduct 'extreme and outrageous.' They've accused the defendants of negligence and intentional infliction of emotional distress, among other claims, for an unspecified amount in damages. 'It was, and it is still, in my heart that I got in my car and I smelled death,' Lawrence Butler told the Associated Press. 'I had to get rid of that car,' he added. 'I just couldn't stand the idea that the remains were in that car.' Stewart told the AP that after speaking to several other funeral homes, he learned the brain is not typically 'separated from [the] body in that fashion and shipped in that fashion.' In the circumstances that the body parts are separated, they are labeled as a biohazard. 'There's no excuse, there is zero excuse for this type of error to happen. For the Georgia funeral home, Southern Cremations, to ship unmarked, bio-hazardous material. For the funeral home here in Philadelphia to hand the parents an unmarked box, not examined, not on a list of the inventory that was the personal items, to not check it,' Stewart told the AP. 'They have not received a single apology to this day from any funeral home.' The owner of Nix & Nix Funeral Homes said that his team didn't know that the box contained brain matter and noted that the state board did a thorough investigation and cleared them of wrongdoing. "Any body parts should be in the body. I don't understand why they would send his brains in a box, a regular box," Julian Nix, the owner of Nix and Nix Funeral Home, told Fox 5. "We immediately reported it to the state board and the medical examiner for inspection," Nix told the outlet. "When the state board investigated, they said that we did everything correct."
